Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Icro Maremmani"'
Autor:
Julien Guiraud, Giovanni Addolorato, Mariangela Antonelli, Henri-Jean Aubin, Andrea de Bejczy, Amine Benyamina, Roberto Cacciaglia, Fabio Caputo, Maurice Dematteis, Anna Ferrulli, Anna E Goudriaan, Antoni Gual, Otto-Michael Lesch, Icro Maremmani, Antonio Mirijello, David J Nutt, François Paille, Pascal Perney, Roch Poulnais, Quentin Raffaillac, Jürgen Rehm, Benjamin Rolland, Claudia Rotondo, Bruno Scherrer, Nicolas Simon, Katrin Skala, Bo Söderpalm, Lorenzo Somaini, Wolfgang H Sommer, Rainer Spanagel, Gabriele A Vassallo, Henriette Walter, Wim van den Brink
Publikováno v:
Journal of Psychopharmacology
Journal of Psychopharmacology, 2022, 36 (10), pp.1136-1145. ⟨10.1177/02698811221104063⟩
Journal of psychopharmacology (Oxford, England), 36(10), 1136-1145. SAGE Publications Ltd
Journal of Psychopharmacology, 2022, 36 (10), pp.1136-1145. ⟨10.1177/02698811221104063⟩
Journal of psychopharmacology (Oxford, England), 36(10), 1136-1145. SAGE Publications Ltd
Background: Sodium oxybate (SMO) has been shown to be effective in the maintenance of abstinence (MoA) in alcohol-dependent patients in a series of small randomized controlled trials (RCTs). These results needed to be confirmed by a large trial inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16dfcadee780a6ce730aa09bdf307b29
https://www.hal.inserm.fr/inserm-04057658
https://www.hal.inserm.fr/inserm-04057658
Autor:
Angelo Giovanni Icro Maremmani, Lucia Sarandrea, Icro Maremmani, Marina Ricci, Manuel Glauco Carbone, Claudia Tagliarini, Anna M. Lupi, Angela Ceban, Pietro Casella
Publikováno v:
CNS spectrums. 26(1)
BackgroundFor some time now, there has been a strong consensus that the migration process can influence the onset, course, development, outcome, and clinical aspects of psychiatric pathologies.MethodsIn this study, we have analyzed the influence of t
Autor:
Angelo Giovanni Icro Maremmani, Corrado Manni, Alessandro Pallucchini, Giulio Perugi, Icro Maremmani, Giada Cipollone
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 16, Iss 20, p 3911 (2019)
International Journal of Environmental Research and Public Health
Volume 16
Issue 20
International Journal of Environmental Research and Public Health
Volume 16
Issue 20
Background: Cocaine use disorder (CUD) is a growing public health concern, but so far no effective pharmacotherapies have been demonstrated. Stimulant medications have proved to be promising in CUD treatment. The self-medication hypothesis (SMH) can
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 922, p 922 (2021)
International Journal of Environmental Research and Public Health
Volume 18
Issue 3
International Journal of Environmental Research and Public Health
Volume 18
Issue 3
A large amount of the current literature has focused on the characteristic symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. In contrast, less attention has been devoted to ADHD clinical subtypes in adult patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1cc9b8944193384e282a8b6ec78dad3
http://hdl.handle.net/11568/1114085
http://hdl.handle.net/11568/1114085
Autor:
Manuel Glauco, Carbone, Giovanni, Pagni, Marco, Maiello, Claudia, Tagliarini, Lorenza, Pratali, Bruno, Pacciardi, Icro, Maremmani
Publikováno v:
Rivista di psichiatria. 55(3)
The Mountain Activities Neuro-behavioural Research Programme is a research project born in the 2 nd Unit of Psychiatry, Department of Clinical and Experimental Medicine at the University of Pisa to investigate the effects of altitude on the mental an
Autor:
Jelena Jović, Icro Maremmani, Aleksandar Ćorac, Darko Hinić, Hagop S. Akiskal, Dina Popovic, Kareen K. Akiskal, Dragana Ristić-Ignjatović
Publikováno v:
Psychiatria Danubina. 31(3)
Background: Previous studies suggest that temperament features of adolescents may be good predictors of the development of future psychopathology in this population. The aim of the study was to adapt the content and validate the psychometric properti
Autor:
Valentina Casetti, Giancarlo Giupponi, Jacopo V. Bizzarri, Stefania Mulas, Claudia Zitelli, Andreas Conca, Antonio Fanolla, Alessandro Briani, Icro Maremmani, Juliane Unterhauser, Patrizia Panzani
Publikováno v:
Comprehensive Psychiatry, Vol 70, Iss, Pp 9-16 (2016)
Background: Mental disorders are associated with an increased prevalence of substance use disorders (SUDs). Despite this comorbidity being firmly established, alcohol and nicotine risky use and misuse are not routinely and systematically assessed in
Autor:
Angelo Giovanni Icro Maremmani, Esterina Pascale, Silvia Cimino, Claudio D'Addario, Luca Cerniglia, Giulia Ballarotto, Eleonora Marzilli, Renata Tambelli, Walter Adriani
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 16, Iss 14, p 2567 (2019)
International Journal of Environmental Research and Public Health
Volume 16
Issue 14
International Journal of Environmental Research and Public Health
Volume 16
Issue 14
Parental psychopathological risk is considered as one of the most crucial features associated with epigenetic modifications in offspring, which in turn are thought to be related to their emotional/behavioral profiles. The dopamine active transporter
Autor:
Giulio Perugi, Marco Maiello, Alessandro Pallucchini, Iacopo Belcari, Icro Maremmani, Francesca Brizzi, Manuel Glauco Carbone, Angelo Giovanni Icro Maremmani, Ciro Conversano
Publikováno v:
Comprehensive Psychiatry, Vol 80, Iss, Pp 132-139 (2018)
Introduction: The severity of emotional responses to life events (PTSD spectrum) as part of Post Traumatic Stress Disorder (PTSD) in Substance Use Disorder (SUD) patients has often been considered from a unitary perspective. Light has also been shed
Autor:
Luisa De Risio, Marco Di Nicola, Sergio De Filippis, Massimo Di Giannantonio, Simone De Persis, Mauro Pettorruso, Giovanni Martinotti, Icro Maremmani, Angelo Giovanni Icro Maremmani, Luigi Janiri
Publikováno v:
Advances in therapy. 34(7)
Nalmefene is the first drug to be approved for reducing alcohol consumption in alcohol use disorder (AUD) patients at high drinking risk. In real-world settings, there is a high prevalence of concurrent psychiatric disorders in AUD subjects, with ass